These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 30334969)
1. Gene pair based prognostic signature for colorectal colon cancer. Shu P; Wu J; Tong Y; Xu C; Zhang X Medicine (Baltimore); 2018 Oct; 97(42):e12788. PubMed ID: 30334969 [TBL] [Abstract][Full Text] [Related]
2. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer. Li B; Cui Y; Diehn M; Li R JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838 [TBL] [Abstract][Full Text] [Related]
3. A prognostic index based on an eleven gene signature to predict systemic recurrences in colorectal cancer. Kim SK; Kim SY; Kim CW; Roh SA; Ha YJ; Lee JL; Heo H; Cho DH; Lee JS; Kim YS; Kim JC Exp Mol Med; 2019 Oct; 51(10):1-12. PubMed ID: 31578316 [TBL] [Abstract][Full Text] [Related]
4. Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer. Mo S; Dai W; Xiang W; Li Y; Feng Y; Zhang L; Li Q; Cai G Carcinogenesis; 2019 Jul; 40(7):861-870. PubMed ID: 30933267 [TBL] [Abstract][Full Text] [Related]
5. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer. Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841 [No Abstract] [Full Text] [Related]
6. Identification of a novel gene pairs signature in the prognosis of gastric cancer. Peng PL; Zhou XY; Yi GD; Chen PF; Wang F; Dong WG Cancer Med; 2018 Feb; 7(2):344-350. PubMed ID: 29282891 [TBL] [Abstract][Full Text] [Related]
7. Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients. Ke J; Liu XH; Jiang XF; He Z; Xiao J; Zheng B; Chen YF; Cai ZR; Zheng XB; Zou YF; Lan P; Wu XJ; Gao F Eur J Surg Oncol; 2020 Oct; 46(10 Pt B):e62-e70. PubMed ID: 32863096 [TBL] [Abstract][Full Text] [Related]
8. Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer. Matsuyama T; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kawano T; Uetake H; Goel A Mol Cancer; 2019 Feb; 18(1):19. PubMed ID: 30717807 [TBL] [Abstract][Full Text] [Related]
9. Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients. Ji D; Qiao M; Yao Y; Li M; Chen H; Dong Q; Jia J; Cui X; Li Z; Xia J; Gu J EBioMedicine; 2018 Sep; 35():189-197. PubMed ID: 30166271 [TBL] [Abstract][Full Text] [Related]
11. Identification of an EMT-related Gene Signature Predicting Recurrence in Stage II/III Colorectal Cancer: A Retrospective Study in 1780 Patients. Ren H; Bösch F; Pretzsch E; Jacob S; Westphalen CB; Walter Holch J; Werner J; Angele MK Ann Surg; 2022 Nov; 276(5):897-904. PubMed ID: 35880752 [TBL] [Abstract][Full Text] [Related]
12. CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer. Nguyen MN; Choi TG; Nguyen DT; Kim JH; Jo YH; Shahid M; Akter S; Aryal SN; Yoo JY; Ahn YJ; Cho KM; Lee JS; Choe W; Kang I; Ha J; Kim SS Oncotarget; 2015 Oct; 6(31):31674-92. PubMed ID: 26397224 [TBL] [Abstract][Full Text] [Related]
13. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer. Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222 [TBL] [Abstract][Full Text] [Related]
14. An immune, stroma, and epithelial-mesenchymal transition-related signature for predicting recurrence and chemotherapy benefit in stage II-III colorectal cancer. Cai D; Wang W; Zhong ME; Fan D; Liu X; Li CH; Huang ZP; Zhu Q; Lv MY; Hu C; Duan X; Wu XJ; Gao F Cancer Med; 2023 Apr; 12(7):8924-8936. PubMed ID: 36629124 [TBL] [Abstract][Full Text] [Related]
15. Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers. Ghatak S; Mehrabi SF; Mehdawi LM; Satapathy SR; Sjölander A Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054980 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer. Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer. Gharib E; Nasrinasrabadi P; Zali MR PLoS One; 2020; 15(3):e0229864. PubMed ID: 32155177 [TBL] [Abstract][Full Text] [Related]
18. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer. Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239 [TBL] [Abstract][Full Text] [Related]
19. IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal Cancers. Fu T; Pappou EP; Guzzetta AA; Calmon Mde F; Sun L; Herrera A; Li F; Wolfgang CL; Baylin SB; Iacobuzio-Donahue CA; Tong W; Ahuja N Ann Surg; 2016 Feb; 263(2):337-44. PubMed ID: 25822686 [TBL] [Abstract][Full Text] [Related]
20. Identification of a five-gene signature with prognostic value in colorectal cancer. Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]